Safety study of BSY001 in healthy adults
Treatments studied
Part of Infections clinical trials.
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in good general health with no major medical conditions.
- Your body mass index (BMI) is between 19 and 30, and your weight is within the study limits.
- You agree to use effective birth control from 1 month before the study until 6 months after the last dose, and you are not planning to have children, donate sperm, or donate eggs.
- You have not taken any prescription or over-the-counter drugs (including herbal supplements) within the last 30 days.
- You do not have a history of allergies to the study drug or its ingredients, and you are not allergic to more than one substance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tecovirimat for people exposed to or infected with viruses like smallpox, monkeypox, or cowpox, and for those with serious vaccine reactions. The medicine may help treat these infections and prevent complications.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
Hear when a new Smallpox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.